TuHURA Biosciences, Inc. (HURA) vs LENZ Therapeutics, Inc. (LENZ)
A side-by-side comparison of TuHURA Biosciences, Inc. and LENZ Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HURA
TuHURA Biosciences, Inc.
$1.92HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
LENZ
LENZ Therapeutics, Inc.
$3.79HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
Total return — HURA vs LENZ
growth of $100 · dividends reinvested · last 5yHURA -98.4% (-56.4%/yr)LENZ -91.4% (-38.7%/yr)LENZ compounded faster over this window
Log scale — wide-divergence pair
HURA LENZ
HURA vs LENZ: by the numbers
- •HURA is the larger company ($122M vs $119M market cap).
- •Both run net losses; HURA's is the smaller (0.00% vs -586.74% net margin).
Metrics side by side
Valuation
| Metric | HURA | LENZ |
|---|---|---|
| P/S ratio | N/A | 5.53 |
| P/B ratio | 6.71 | 0.54 |
Profitability
| Metric | HURA | LENZ |
|---|---|---|
| Gross margin | 0.00% | 90.14% |
| Operating margin | 0.00% | -477.46% |
| Net margin | 0.00% | -586.74% |
| ROE | -165.57% | -57.47% |
| ROIC | -137.40% | -61.84% |
Growth (annualized)
| Metric | HURA | LENZ |
|---|---|---|
| Total return CAGR (5Y) | -45.49% | -35.49% |
Frequently asked
- How have HURA and LENZ total returns compared?
- Over the past 5 years, HURA delivered -45.49% and LENZ delivered -35.49% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.